| |
|
|
 Equity Holding 7 – FORTIS HEALTHCARE
|
| |
Fortis Healthcare Limited was established in 1996 by the promoters of Ranbaxy Laboratories. Ranbaxy is among the world’s top 10 generic pharmaceutical companies and India’s largest pharmaceutical company. Fortis Healthcare has a network of 11 hospitals, primarily in North India, and 16 satellite and heart command centres.
The hospitals include multi-specialty and super-specialty centres, providing healthcare to patients in cardiac care, orthopaedics, neurosciences, oncology, renal care, gastroenterology and mother and child care.
Fortis has initiated the implementation of the following projects:
- a super-specialty hospital in West Delhi,
with focus on cardiac care, neurosciences, renal sciences, mother and
child care and gastroenterology (Phase 1: 250 beds)
- a super-specialty hospital in Gurgaon, with
a focus on trauma, oncology, mother and child care, orthopaedics, organ
transplants and neurosciences (Phase 2: 350 beds)
|
|
| |
| |
 |
| |  |
|
| |
| |
| |
| View Project Details |
|
|
|
|
| £8.2 million* |
| Asset Class |
Infrastructure |
| Project Name |
Fortis Healthcare Limited(‘FHL’)
|
| Partner |
Ranbaxy Group |
Location
|
Pan India |
| Type |
Healthcare facilities, hospitals |
| Saleable Area |
26.6 acres consolidated across the 4 projects |
| Capital Invested |
£13.5 M |
| *NAV as of 31 March 2008 |
£8.2 M |
| IRR at Date |
(38%) |
| Multiple at Date |
0.61 |
| Stock Exchange |
Bombay Stock Exchange — Ticker: Fortis |
|
**Current percentage holding of total number of shares is 3.5%.
|
